GENZPRO’s ELISA-based microfluidic chip is coated with Sars-Cov-2 antigens, precisely detecting targeted human IgG antibodies in one drop of blood, serum, or plasma.
GENZPRO device is a connected stand-alone, portable device that analyses GENZPRO’s test chip in 5 minutes, reports the results to the patient, the doctor, and/or central information systems.
GENZPRO Antibody Rapid test shows the immune response of patients against the Covid-19 virus after 2-14 weeks from the infection or after vaccination in a reliable way.